Search

Candida auris central line infection

clabsi

“We report the first isolate of C. auris in Cali, Colombia, from a central venous catheter in a 37-year-old patient with rheumatoid arthritis and endocarditis who did not have symptoms of sepsis” Castro et al (2019).

PICC management in elderly patients

OPAT

“These results suggest that PICC is useful and does not cause serious adverse effects, even in elderly patients who require central parenteral nutrition management” Ishiyama and Sudo (2020).

Central catheter surface type encourages biofilm formation

central venous catheter

“This information provides guidance in regard to the preparation of hyperosmolar total parenteral nutrition and the engineering of CVC surfaces that can minimize the risk of catheter-related bloodstream infections caused by S. capitis in the NICU” Qu et al (2020).

Chlorhexidine allergy associated with IV site skin cleansing

chlorhexidine allergy

“We present a case-report of a teenager, treated for acute lymphoblastic leukemia who developed an anaphylactic shock after repeated chlorhexidine use for skin disinfection at the insertion of a central venous catheter during his chemotherapy treatment” Devinck et al (2020).

Management of ampicillin infusions in the outpatient setting

Antibiotic infusion

“The use of ampicillin in the outpatient setting has traditionally been avoided due to its short half-life and instability in solution. However, recent in vitro data and two recent case series have supported the safe and effective administration of ampicillin by continuous infusion in the community” Parsonson et al (2020).

Central catheter-associated complications in the PICU

neonatal picc

“We aimed to identify the occurrence and risk factors for unplanned catheter removal due to catheter-associated complications and the effects on catheter survival probability in a PICU” Shimizu et al (2020).

IV site observation during total intravenous anaesthesia – Full Text

picc line prevalence

“These publications also recommend processed EEG ‘depth of anaesthesia’ monitoring when TIVA is used with a neuromuscular blocking (NMB) drug and the TIVA guidelines recommend a lower threshold for its use when the i.v. access site is not continuously visible” Davies et al (2020).

When should intraosseous access be considered a first-line option?

IO

“In cases in which there is an urgent need for medications and fluid resuscitation, whether in infants, children, or adults, and immediate intravenous access is not easily obtainable, intraosseous access should be considered as a first-line option” DeBoer et al (2020).

Register for free citation alerts

Supporting your vascular access and infusion therapy learning journey